[#item_full_content] MAPS selects Changemark as CRO for $12.9M Phase 2 cannabis PTSD study in Veterans, advancing toward Q1 2026 treatment start…. Read More
[#item_full_content] MAPS selects Changemark as CRO for $12.9M Phase 2 cannabis PTSD study in Veterans, advancing toward Q1 2026 treatment start…. Read More